CeGaT Expands Genetic Testing Services to U.S. and Canada, Partnering with Major Insurers
CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic…
CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic…
CeGaT, a global provider of genetic diagnostics and sequencing services, presents an innovation in exome diagnostics: Wi…
Molecular Health (MH), ein international tätiges Biotech-IT-Unternehmen aus Heidelberg, das auf Basis seiner proprietäre…
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QIAGEN Clinical Insight (QCI®), its clinical dec…
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Einführung von drei innovativen „Sample to Insight…
Molecular Health (MH), ein führendes Präzisionsmedizin Unternehmen, das sich auf die Vermarktung von Produkten und Servi…
Centogene AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of C…
Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics,…
With the upcoming release of CentoMD® 3.1 end of September 2016, CENTOGENE will report genetic information and clinical…
CENTOGENE AG (“CENTOGENE”) announces the launch of the completely updated CentoMD® 3.0 CentoMD®, the world’s leading pr…